Quanex Building Products (NX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Quanex is proposing to acquire Tyman plc through a court-sanctioned scheme of arrangement, with a special meeting scheduled for July 12, 2024, for shareholder approval of new share issuance to Tyman shareholders.
The transaction values Tyman at approximately £788 million ($975 million), offering Tyman shareholders either a mix of cash and Quanex shares or an all-share alternative, capped at 25% of Tyman shares.
Upon completion, Tyman shareholders will own between 30% and 32% of the combined company, with Quanex shareholders retaining 68% to 70%.
The boards of both companies unanimously recommend the transaction, citing strategic rationale, complementary product portfolios, and significant synergy opportunities.
Voting matters and shareholder proposals
Quanex shareholders will vote on two proposals: approval of new share issuance for the Tyman acquisition and potential adjournment of the meeting to solicit additional proxies if needed.
Approval requires a majority of shares present or represented by proxy at the meeting.
The board recommends voting in favor of both proposals.
Board of directors and corporate governance
Post-transaction, Quanex’s current board will remain, with George Wilson continuing as Chairman, President, and CEO.
All non-executive Tyman directors will resign upon completion.
A board observer right is granted to any Tyman shareholder meeting certain ownership thresholds.
Latest events from Quanex Building Products
- Net sales rose 2.3% to $409.1 million, but adjusted EBITDA margin declined to 6.7%.NX
Q1 20266 Mar 2026 - Q2 sales declined but margins improved; FY24 guidance and Tyman acquisition progress reaffirmed.NX
Q2 20241 Feb 2026 - Board recommends voting for all directors, executive pay, and new auditor, with strong governance and ESG focus.NX
Proxy Filing28 Jan 2026 - Q3 results met expectations; Tyman acquisition closed, integration progressing, and FY24 guidance raised.NX
Q3 202421 Jan 2026 - Tyman acquisition drove record sales and margin gains, with a 2025 rebound expected.NX
Q4 202411 Jan 2026 - Q3 sales jumped 77% with Tyman, but a $302.3M goodwill impairment led to a $276M net loss.NX
Q3 202531 Dec 2025 - Targets ~$4B revenue by 2029, leveraging Tyman synergies, innovation, and margin expansion.NX
Investor Day 202529 Dec 2025 - Sales up 67% in Q1, net loss $14.9M, guidance reaffirmed, synergy and margin gains on track.NX
Q1 202526 Dec 2025 - Net sales up 43.8% to $1.84B; Monterrey recovery and strong cash flow drive debt reduction.NX
Q4 202513 Dec 2025